← Wegovy
Episodes featuring Wegovy
72 episodes, newest first.
- Sep 2, 2026
GLP-1 drugs push Big Food beyond indulgenceThe Journal.Sep 2, 2026 - Sep 1, 2026
Iowa State starts over under Jimmy RogersCyclone FanaticSep 1, 2026 - Aug 31, 2026
Cliff Nonnenmacher sees value where failing businesses hideFounder's StoryAug 31, 2026 - Aug 29, 2026
GLP-1s demand more than a prescriptionMind Pump: Raw Fitness TruthAug 29, 2026 - Aug 29, 2026
Floods, rate hikes and weight loss reshape the news agendaReuters World News Aug 29, 2026 - Aug 29, 2026
Three UFO cases leave deaths and evidence unexplainedThe Why Files: Operation PodcastAug 29, 2026 - Aug 24, 2026
Stocks react to analyst calls as cities plan for AI-driven growthStock MoversAug 24, 2026 - Aug 21, 2026
GLP-1 drugs may reshape gut health beyond weight lossThe Thyroid (and Hormone) Fixer Podcast: Thyropause, Menopause, Metabolism and How to Fix ItAug 21, 2026 - Aug 18, 2026
Speed still defines the ideal action movieThe RewatchablesAug 18, 2026 - Aug 16, 2026
GLP-1 drugs reshape appetite science and metabolic medicineThe Rest Is ScienceAug 16, 2026 - Aug 14, 2026
GLP-1 drugs could rewrite the economics of eatingBig Technology PodcastAug 14, 2026 - Aug 12, 2026
Cramer weighs durable growth against market noiseMad Money w/ Jim CramerAug 12, 2026 - Aug 12, 2026
GLP-1 treatment works best beyond the scaleThe Dr. Hyman ShowAug 12, 2026 - Aug 7, 2026
AI integration divides tech earnings as floating nuclear reactors eye data centersThis Week in StartupsAug 7, 2026 - Aug 7, 2026
David Sinclair reveals how gene therapy and AI are reversing cellular agingThe Joe Rogan ExperienceAug 7, 2026 - Aug 5, 2026
Novo Nordisk stumbles as AI valuation fears hit European stocksStock MoversAug 5, 2026 - Jul 3, 2026
Paul Scott cuts market talk short for a Halfords bike rideUK Small/Mid Caps with Paul ScottJul 3, 2026 - Jun 16, 2026
SpaceX subsidiary merges with Cursor in sixty billion dollar AI dealStock MoversJun 16, 2026 - Jun 11, 2026
Dean Radin challenges scientific materialism and explores the science of consciousnessThe Joe Rogan ExperienceJun 11, 2026 - Jun 1, 2026
Clinicians warn of sourcing risks amid the rapid rise of peptide therapeuticsHuberman LabJun 1, 2026 - May 1, 2026
Hyperscalers risk overbuilding as OpenAI misses revenue targetsAll-In with Chamath, Jason, Sacks & FriedbergMay 1, 2026 - Feb 5, 2026
Cramer warns rotation punishes high-flying stocksMad Money w/ Jim CramerFeb 5, 2026 - Jan 13, 2026
Healthcare CEOs pitch obesity drugs and device breakthroughsMad Money w/ Jim CramerJan 13, 2026 - Dec 10, 2025
Executives defend turnarounds across AI, defense and bankingMad Money w/ Jim CramerDec 10, 2025